{"database": "lobbying", "table": "lobbying_activities", "rows": [[3242138, "81798433-6752-4449-ab3f-64d58a7b7a15", "Q3", "IPOLICY SOLUTIONS", 401105127, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2024, "third_quarter", "MED", "No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to \"Medical Devices; Laboratory Developed Tests\"", "HOUSE OF REPRESENTATIVES,SENATE", 70500, null, 0, 0, "2024-10-17T10:14:36-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3242138"], "units": {}, "query_ms": 4.178059054538608, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}